ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 185 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $407,000 | +1353.6% | 12,900 | +2604.4% | 0.00% | – |
| Q4 2019 | $28,000 | -59.4% | 477 | -74.7% | 0.00% | – |
| Q3 2019 | $69,000 | +27.8% | 1,889 | +62.3% | 0.00% | – |
| Q2 2019 | $54,000 | +5300.0% | 1,164 | +11540.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 10 | -91.9% | 0.00% | – |
| Q4 2016 | $2,000 | -99.5% | 124 | -99.6% | 0.00% | -100.0% |
| Q3 2016 | $413,000 | +18.7% | 29,855 | -15.2% | 0.00% | 0.0% |
| Q2 2016 | $348,000 | +23.0% | 35,219 | +193.5% | 0.00% | 0.0% |
| Q3 2015 | $283,000 | -42.4% | 12,000 | +100.0% | 0.00% | 0.0% |
| Q2 2015 | $491,000 | -11.7% | 6,000 | 0.0% | 0.00% | -50.0% |
| Q1 2015 | $556,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |